No abstract available
Keywords:
Adverse events; efficacy; glycopyrrolate; oxybutynin; sofpironium; therapy; umeclidinium.
MeSH terms
-
Administration, Topical
-
Cholinergic Antagonists / administration & dosage*
-
Cholinergic Antagonists / pharmacology
-
Drug Development
-
Drugs, Investigational / administration & dosage
-
Drugs, Investigational / pharmacology
-
Humans
-
Hyperhidrosis / drug therapy*
Substances
-
Cholinergic Antagonists
-
Drugs, Investigational